Celia Berkers

The Berkers group combines Metabolomics – studying the small molecule metabolite profile of cells using Mass Spectrometry – with biochemical and chemical biology techniques. By comprehensively profiling metabolic changes in either drug resistant cells or in specific populations of immune cells, we aim to identify novel targets for therapeutic intervention.